Body fat distribution and plasma lipid profiles of patients with multiple sclerosis
Yıl: 2004 Cilt: 34 Sayı: 1 Sayfa Aralığı: 43 - 48 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022
Body fat distribution and plasma lipid profiles of patients with multiple sclerosis
Öz: This study was performed to determine the body fat percentage, fat distribution and plasma lipid-cholesterol levels of patients with multiple sclerosis (MS). We compared the body fat percentage, distribution and lipid profile in 22 patients with definitive diagnosis of MS and age and height matched 16 healthy control subjects on normal diets. Poser criteria was used to determine the MS diagnosis. Body fat percentage and distribution were evaluated anthropometrically by measuring skin fold thickness from 7 different reference points of the body. The parameters of the body composition were obtained by using the equations of Durning, Womersly and Siri. Body fat distribution was calculated by using Mueller's formulation. The plasma levels of total cholesterol, high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), very low density lipoprotein-cholesterol (VLDL-C) and triglycerides were measured spectrophotometrically in patients and healthy volunteers. The mean body fat percentage of male MS patients was significantly the lower than in the male controls (P < 0.05). Body mass index and lean body mass of MS patients did not differ from the controls of either sex. The ratio of central to peripheral body fat was lower in all MS patients. Although male patients had a lower ratio, the difference with the control group was not statistically significant. The ratio of upper to lower body fat in male patients was significantly higher than in the controls (P < 0.05). This difference was not present in the female population. Mean plasma total cholesterol levels were slightly higher in MS patients than in healthy volunteers, but this was not significant. Mean plasma HDL-C and LDL-C levels of the MS patients were not statistically different from the values of the controls. The levels of plasma VLDL-C and triglycerides of patients were significantly higher than the levels of healthy subjects (P < 0.05). Our results show that total subcutaneous fat stores of the body were diminished in male MS patients. Truncal and lower body fat of MS patients was reduced and upper body fat was increased when compared to the controls. Plasma levels of VLDL-C and triglycerides were also found to be higher in MS patients. It is considered that lipid metabolism can be influenced by MS. Further studies are needed to investigate how the fat storage process changes and to understand the importance of alterations in the plasma lipid profile in the course of MS.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Esparza Ml, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol; 142: 733-737, 1995. 2. Formica CA, Cosman F, Nievers J et al. Reduced bone mass and fat-free mass in women with multiple sclerosis: Effects of ambulatory status and glucocorticod use. Calcif Tissue Int 61: 129-133, 1997. 3. Sayetta RB. Theories of the etiology of multiple sclerosis: A critical review. J Clin Lab Immunol 21: 55-70, 1986. 4. Petejan JH, Gappmaier E, White AT et al. Impact of aerobic training of fitness and quality of life in multiple sclerosis. Ann Neurol 39: 432-441, 1996. 5. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336: 37-39, 1990. 6. Swank RL, Grimgard A. Multiple sclerosis: the lipid relationship. Am J Clin Nutr 48: 1387-1393, 1998. 7. Swank RL. Multiple sclerosis: Fat-oil relationship. Nutrition 7: 368-376, 1991. 8. Cunnane SC, Ho SY, Dore-Duffy P et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr 50: 801-806, 1989. 9. A, Minghetti L, Sette G et al. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53: 1876-1879, 1999. 10. Cheragil GD. Effects of in vitro hyperthermia on fatty acids of red blood cells and plasma lipids from patients with multiple sclerosis. J Neurol Sci 95: 141-151, 1990. 11. Sugera XNR. Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurol Scand 78: 152-157, 1988. 12. Newcombe J, Lihe D, Cuzner ML. Low density lipoprotein uptake by macrophage in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20: 152-162, 1994. 13. Nue IS, Prosiegel M, Pfafenrath V. Platelet aggregation and multiple sclerosis. Acta Neurol Scand 66: 497-504, 1982. 14. Nue IS. Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol Scand 7: 151-163, 1983. 15. Ben-Shlomo Y, Davey Smith G, Marmot MG. Dietary fat in the epidemiology of multiple sclerosis: has the stimulation been adequately assessed. Neuroepidemiology 11: 214-225, 1992. 16. Navarro X, Segura R. Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurol Scand 78: 152- 157, 1988. 17. Nanji AA, Narod S. Multiple sclerosis, latitude and dietary fat: is pork the missing link? Med Hypotheses 20: 279-282, 1986. 18. Fernandez O. Multiple sclerosis and a fat-poor diet. Neurologia 6: 235-237, 1991.
- 19. Alberts JJ, Marcovina SM, Christensen RH. Lecithin cholesterol acyltransferase in human cerebrospinal fluid: Reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain. Int J Clin Lab Res 22: 169-172, 1992. 20. Baker RWR, Thompson RHS, Zilkha KJ. Fatty acid composition of brain lecithins in multiple sclerosis. Lancet 1: 26-27, 1963. 21. Mc Neil G, Fowler PA, Maughan RJ et al. Body fat in lean and overweight women estimated by six methods. British Journal of Nutrition 65: 95-103, 1991. 22. Mueller WH, Wear Ml, Hanis CL et al. Which measure of body fat distribution is best for epidemiologic research? American Journal of Epidemiologia 133: 858-869, 1991. 23. Swank Rl, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336: 37-39, 1990. 24. Navarro X, Segura R. Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurologica Scandinavia 1988; 78: 152-157, 1998. 25. Cunnane SC, Hoe SY, Dore-Duffy P et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. American Journal of Clinical Nutrition 50: 801-806, 1989. 26. Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R. Reduced bone mass and fat-free mass in women with multiple sclerosis: Effects of ambulatory status and glucocorticoid use. Calcified Tissue Int 61: 129-133, 1997. 27. Roubenoff R, Rall LC. Humoral mediation of changing body composition during aging and chronic inflammation. Nutrition Reviews 51: 1-11, 1993. 28. Maghraoui AE, Borderie D, Cherruau B et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26: 2205-2209, 1999. 29. Freedman DS, Jacobsen SJ, Barboriak JJ et al. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 81: 1498-1506, 1990. 30. Westhovens R, Wijs J, Taelman V et al. Body composition in rheumatoid arthritis. Br J Rheumatol 36: 444-448, 1997. 31. Kent-Braun JA, Castro M, Weiner MW et al. Strength, skeletal muscle composition, and enzyme activities in multiple sclerosis. Journal Applied of Physiology 83: 1998-2004, 1997. 32. Greco A, Minghetti L, Sette G et al. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53: 1876-1879, 1999. 33. Svenningsson A, Petersson AS, Andersen O et al. Nitric oxide metabolisms in CSF of patients with MS are related to clinical disease course. Neurology 53: 1880-1882, 1999. 34. Petejan JH, Gappmaier E, White AT et al. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Annual Neurology 39: 432-441, 1996. 35. Durning VGA, Womersly J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. British Journal of Nutrition 32: 77-97, 1974. 36. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. British Journal of Nutrition 65: 105-114, 1991. 37. Gray DS, Bray GA, Bauer M et al. Skinfold thickness measurements in obese subjects. American Journal of Clinical Nutrition 51: 571-577, 1990. 38. Hergenroeder AC, Klish WJ. Body composition in adolescent athletes. Pediatric Clinic North America 37: 1057-1083, 1990. 39. Lohman TG. Skinfolds and body density and their relation to body fatness: A review. Human Biologia 53: 181-225, 1981. 40. Verlooy H, Dequeker J, Geusens P et al. Body composition by intercomparison of underwater weighing, skinfold measurements and dual-photon absorptiometry. British Journal Radiology 64: 765-767, 1991. 41. Hollman RT, Johnson SB, Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 86: 4720-4724, 1989. 42. Sandyk R, Awerbuch GI. The relationship between melatonin secretion and serum cholesterol in patients with multiple sclerosis. Int J Neurosci 76: 81-86, 1994. 43. De Andres C, Liedo A. Fatty diet and multiple sclerosis. Rev Neurol 25: 2032-2035, 1997. 44. Allen IV. The pathology of multiple sclerosis, fact-fiction and hypothesis. Neuropathol Appl Neurobiol 7: 169-182, 1981. 45. Adams CW, Poston RN. Macrophage histology in paraffinembedded multiple sclerosis plaques in demonstrated by the monoclonal pan-macrophage marker HAM-56: Correlation with chronicity of the lesion. Acta Neuropathol 80: 208-211, 1990. 46. Osman I, Gaillard O, Meillet D et al. A sensitive time-resolved immunfluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Eur J Clin Chem Clin Biochem 33: 53-58, 1995. 47. Sepcic J, Mesaros E, Materjan E et al. Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neuroepidemiology 12: 234-240, 1993. 48. Steen G, Axellson H, BowallÝus M et al. Isoprenoid biosynthesis in multiple sclerosis, II. A possible role of NADPH. Acta Neurol Scand 76: 461-467, 1987. 49. Uhlig H, Dernick R. Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system. Autoimmunity 5: 87-89, 1989.
| APA | ÇOMOĞLU S, YARDIMCI S, OKÇU Z (2004). Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. , 43 - 48. |
| Chicago | ÇOMOĞLU Selçuk,YARDIMCI Serdar,OKÇU Zeki Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. (2004): 43 - 48. |
| MLA | ÇOMOĞLU Selçuk,YARDIMCI Serdar,OKÇU Zeki Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. , 2004, ss.43 - 48. |
| AMA | ÇOMOĞLU S,YARDIMCI S,OKÇU Z Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. . 2004; 43 - 48. |
| Vancouver | ÇOMOĞLU S,YARDIMCI S,OKÇU Z Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. . 2004; 43 - 48. |
| IEEE | ÇOMOĞLU S,YARDIMCI S,OKÇU Z "Body fat distribution and plasma lipid profiles of patients with multiple sclerosis." , ss.43 - 48, 2004. |
| ISNAD | ÇOMOĞLU, Selçuk vd. "Body fat distribution and plasma lipid profiles of patients with multiple sclerosis". (2004), 43-48. |
| APA | ÇOMOĞLU S, YARDIMCI S, OKÇU Z (2004). Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. Turkish Journal of Medical Sciences, 34(1), 43 - 48. |
| Chicago | ÇOMOĞLU Selçuk,YARDIMCI Serdar,OKÇU Zeki Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. Turkish Journal of Medical Sciences 34, no.1 (2004): 43 - 48. |
| MLA | ÇOMOĞLU Selçuk,YARDIMCI Serdar,OKÇU Zeki Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. Turkish Journal of Medical Sciences, vol.34, no.1, 2004, ss.43 - 48. |
| AMA | ÇOMOĞLU S,YARDIMCI S,OKÇU Z Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. Turkish Journal of Medical Sciences. 2004; 34(1): 43 - 48. |
| Vancouver | ÇOMOĞLU S,YARDIMCI S,OKÇU Z Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. Turkish Journal of Medical Sciences. 2004; 34(1): 43 - 48. |
| IEEE | ÇOMOĞLU S,YARDIMCI S,OKÇU Z "Body fat distribution and plasma lipid profiles of patients with multiple sclerosis." Turkish Journal of Medical Sciences, 34, ss.43 - 48, 2004. |
| ISNAD | ÇOMOĞLU, Selçuk vd. "Body fat distribution and plasma lipid profiles of patients with multiple sclerosis". Turkish Journal of Medical Sciences 34/1 (2004), 43-48. |
